eAppendix. Estimation of HCV screening cost
We considered two different types of tests for HCV diagnosis: screening test and test for detection of viremia ( Table 1) . We estimated the cost per HCV case diagnosed separately for diagnosis via usual care, and diagnosis via universal screening.
For the diagnosis via usual care, we used the cost of the screening test and the test for viremia; and for the diagnosis via universal screening, the average cost per case diagnosed, , was determined by the following approach:
• First we estimated the number of people needed to screen, , to diagnose one chronic HCV-infected patient:
• Then we estimated the cost of diagnosing one HCV case, as: a The current HCV prevalence is 20% higher (i.e., 9.6 million in 2018) than that in the base case (with 8.0 million). b The current HCV awareness rate is 7% (in contrast to 12.7% in base case in 2018). c For the "Increasing HCV Incidence" Scenario, the incidence reduction target cannot be achieved because the increasing incidence was used as model inputs. The diagnosis and treatment rates were selected based on the feasibility of other three elimination targets.
